Richard Saynor is a CEO of Sandoz and Advocate for Affordable Healthcare, ranked #2 in Health & Medicine (Top 2%).
Last updated
Richard Saynor is the CEO of Sandoz, a global leader in affordable healthcare and generic medicines. He frequently shares updates on Sandoz's financial performance, strategic initiatives, and collaborations with policymakers and industry leaders. His posts emphasize the importance of biosimilars, antibiotics, and affordable healthcare, often highlighting Sandoz's role in expanding access to essential medicines. Saynor engages with global audiences through LinkedIn, discussing topics such as healthcare resilience, innovation, and the future of the pharmaceutical industry.
Access delayed is access denied.
Favikon helps you find the right creators, analyze them in depth, reach out at scale, and track what works.